AD-214
/ Yuhan Corp
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 20, 2022
A Study to Compare PK, PD and Safety of the AD-214 and AD-2141
(clinicaltrials.gov)
- P1 | N=41 | Completed | Sponsor: Addpharma Inc. | Recruiting ➔ Completed
Trial completion • Gastroenterology • Gastroesophageal Reflux Disease
1 to 1
Of
1
Go to page
1